A peptide talk between JC virus and the human host: from silent infection to autoimmunity

References

• Frisque, R.J., Bream, G.L., Cannella, M.T. Human polyomavirus JC virus genome. J Virol 1984, 51, 458–469.
   PubMed Web of Science ®Google Scholar
• Padgett, B.L., Rogers, C.M., Walker, D.L. JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: Additional biological characteristics and antigenic relationships. Infect Immun 1977, 15, 656–662.
   PubMed Web of Science ®Google Scholar
• Berger, J.R., Major, E.O. Progressive multifocal leukoencephalopathy. Semin Neurol 1999, 19, 193–200.
   PubMed Web of Science ®Google Scholar
• Zuckerman, A.J., Banatvala, J.E., Griffiths, P. (2009). Principles and practice of clinical virology. New York: John Wiley & Sons.
   Google Scholar
• Wen, M.C., Wang, C.L., Wang, M., Cheng, C.H., Wu, M.J., Chen, C.H., Shu, K.H., Chang, D. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient. J Med Virol 2004, 72, 675–678.
   PubMed Web of Science ®Google Scholar
• Viallard, J.F., Ellie, E., Lazaro, E., Lafon, M.E., Pellegrin, J.L. JC virus meningitis in a patient with systemic lupus erythematosus. Lupus 2005, 14, 964–966.
   PubMed Web of Science ®Google Scholar
• Boldorini, R., Veggiani, C., Barco, D., Monga, G. Kidney and urinary tract polyomavirus infection and distribution: Molecular biology investigation of 10 consecutive autopsies. Arch Pathol Lab Med 2005, 129, 69–73.
   PubMed Web of Science ®Google Scholar
• Gallia, G.L., Gordon, J., Khalili, K. Tumor pathogenesis of human neurotropic JC virus in the CNS. J Neurovirol 1998, 4, 175–181.
   PubMed Web of Science ®Google Scholar
• Gordon, J., Del Valle, L., Otte, J., Khalili, K. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice. Oncogene 2000, 19, 4840–4846.
   PubMed Web of Science ®Google Scholar
• Gallia, G.L., DelValle, L., Laine, C., Curtis, M., Khalili, K. Concomitant progressive multifocal leucoencephalopathy and primary central nervous system lymphoma expressing JC virus oncogenic protein, large T antigen. MP, Mol Pathol 2001, 54, 354–359.
   PubMedGoogle Scholar
• Enam, S., Del Valle, L., Lara, C., Gan, D.D., Ortiz-Hidalgo, C., Palazzo, J.P., Khalili, K. Association of human polyomavirus JCV with colon cancer: Evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 2002, 62, 7093–7101.
   PubMed Web of Science ®Google Scholar
• Shin, S.K., Li, M.S., Fuerst, F., Hotchkiss, E., Meyer, R., Kim, I.T., Goel, A., Boland, C.R. Oncogenic T-antigen of JC virus is present frequently in human gastric cancers. Cancer 2006, 107, 481–488.
   PubMed Web of Science ®Google Scholar
• Ramamoorthy, S., Devaraj, B., Miyai, K., Luo, L., Liu, Y.T., Boland, C.R., Goel, A., Carethers, J.M. John Cunningham virus T-antigen expression in anal carcinoma. Cancer 2011, 117, 2379–2385.
   PubMed Web of Science ®Google Scholar
• Dubois, V., Dutronc, H., Lafon, M.E., Poinsot, V., Pellegrin, J.L., Ragnaud, J.M., Ferrer, A.M., Fleury, H.J. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J Clin Microbiol 1997, 35, 2288–2292.
   PubMed Web of Science ®Google Scholar
• Andréoletti, L., Dubois, V., Lescieux, A., Dewilde, A., Bocket, L., Fleury, H.J., Wattré, P. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy. AIDS 1999, 13, 1469–1475.
   PubMed Web of Science ®Google Scholar
• Bellizzi, A., Anzivino, E., Ferrari, F., Di Nardo, G., Colosimo, M.T., Fioriti, D., Mischitelli, M., Chiarini, F., Cucchiara, S., Pietropaolo, V. Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn’s disease patients treated with infliximab. J Neurovirol 2011, 17, 303–313.
   PubMed Web of Science ®Google Scholar
• Weissert, R. Progressive multifocal leukoencephalopathy. J Neuroimmunol 2011, 231, 73–77.
   PubMed Web of Science ®Google Scholar
• Iaffaldano, P., Lucchese, G., Trojano, M. Treating multiple sclerosis with natalizumab. Expert Rev Neurother 2011, 11, 1683–1692.
   PubMed Web of Science ®Google Scholar
• Sariyer, I.K., Khalili, K. Regulation of human neurotropic JC virus replication by alternative splicing factor SF2/ASF in glial cells. PLoS ONE 2011, 6, e14630.
   PubMed Web of Science ®Google Scholar
• Wollebo, H.S., Safak, M., Del Valle, L., Khalili, K., White, M.K. Role for tumor necrosis factor-a in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol 2011, 233, 46–53.
   PubMed Web of Science ®Google Scholar
• Antonsson, A., Green, A.C., Mallitt, K.A., O’Rourke, P.K., Pawlita, M., Waterboer, T., Neale, R.E. Prevalence and stability of antibodies to the BK and JC polyomaviruses: A long-term longitudinal study of Australians. J Gen Virol 2010, 91, 1849–1853.
   PubMed Web of Science ®Google Scholar
• Kean, J.M., Rao, S., Wang, M., Garcea, R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5, e1000363.
   PubMed Web of Science ®Google Scholar
• Matos, A., Duque, V., Beato, S., da Silva, J.P., Major, E., Meliço-Silvestre, A. Characterization of JC human polyomavirus infection in a Portuguese population. J Med Virol 2010, 82, 494–504.
   PubMed Web of Science ®Google Scholar
• Chesters, P.M., Heritage, J., McCance, D.J. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983, 147, 676–684.
   PubMed Web of Science ®Google Scholar
• Knowles, W.A. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol 2006, 577, 19–45.
   PubMed Web of Science ®Google Scholar
• Kusalik, A., Bickis, M., Lewis, C., Li, Y., Lucchese, G., Marincola, F.M., Kanduc, D. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes. Peptides 2007, 28, 1260–1267.
   PubMed Web of Science ®Google Scholar
• Kanduc, D., Stufano, A., Lucchese, G., Kusalik, A. Massive peptide sharing between viral and human proteomes. Peptides 2008, 29, 1755–1766.
   PubMed Web of Science ®Google Scholar
• Wu, C.H., Yeh, L.S., Huang, H., Arminski, L., Castro-Alvear, J., Chen, Y., Hu, Z., Kourtesis, P., Ledley, R.S., Suzek, B.E., Vinayaka, C.R., Zhang, J., Barker, W.C. The Protein Information Resource. Nucleic Acids Res 2003, 31, 345–347.
   PubMed Web of Science ®Google Scholar
• Capone, G., Novello, G., Fasano, C., Trost, B., Bickis, M., Kusalik, A., Kanduc, D. The oligodeoxynucleotide sequences corresponding to never-expressed peptide motifs are mainly located in the non-coding strand. BMC Bioinformatics 2010, 11, 383.
   PubMed Web of Science ®Google Scholar
• Peters, B., Sidney, J., Bourne, P., Bui, H.H., Buus, S., Doh, G., Fleri, W., Kronenberg, M., Kubo, R., Lund, O., Nemazee, D., Ponomarenko, J.V., Sathiamurthy, M., Schoenberger, S., Stewart, S., Surko, P., Way, S., Wilson, S., Sette, A. The immune epitope database and analysis resource: From vision to blueprint. PLoS Biol 2005, 3, e91.
   PubMed Web of Science ®Google Scholar
• Davey, N.E., Edwards, R.J., Shields, D.C. Computational identification and analysis of protein short linear motifs. Front Biosci 2010, 15, 801–825.
   Web of Science ®Google Scholar
• Li, F., Carlsson, D., Lohmann, C., Suuronen, E., Vascotto, S., Kobuch, K., Sheardown, H., Munger, R., Nakamura, M., Griffith, M. Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation. Proc Natl Acad Sci USA 2003, 100, 15346–15351.
   PubMed Web of Science ®Google Scholar
• Li, F., Griffith, M., Li, Z., Tanodekaew, S., Sheardown, H., Hakim, M., Carlsson, D.J. Recruitment of multiple cell lines by collagen-synthetic copolymer matrices in corneal regeneration. Biomaterials 2005, 26, 3093–3104.
   PubMed Web of Science ®Google Scholar
• Kim, J.M., Lee, Y.H., Ku, C.R., Lee, E.J. The cyclic pentapeptide d-Arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice. Endocrinology 2011, 152, 536–544.
   PubMed Web of Science ®Google Scholar
• Kamiya, M., Oyauchi, K., Sato, Y., Yokoyama, T., Wang, M., Aizawa, T., Kumaki, Y., Mizuguchi, M., Imai, K., Demura, M., Suzuki, K., Kawano, K. Structure-activity relationship of a novel pentapeptide with cancer cell growth-inhibitory activity. J Pept Sci 2010, 16, 242–248.
   PubMed Web of Science ®Google Scholar
• Singh, J.P., Tamang, S., Rajamohanan, P.R., Cheng, C.H., Wu, M.J., Chen, C.H., Shu, K.H., Chang, D. Isolation, structure, and functional elucidation of a modified pentapeptide, cysteine protease inhibitor (CPI-2081) from Streptomyces species 2081 that exhibit inhibitory effect on cancer cell migration. J Med Chem 2010, 53, 5121–5128.
   PubMed Web of Science ®Google Scholar
• Girnys, E.A., Sobczyk-Kojiro, K., Mosberg, H.I. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19. Chem Biol Drug Des 2010, 75, 35–39.
   PubMed Web of Science ®Google Scholar
• Leali, D., Bianchi, R., Bugatti, A., Nicoli, S., Mitola, S., Ragona, L., Tomaselli, S., Gallo, G., Catello, S., Rivieccio, V., Zetta, L., Presta, M. Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide. J Cell Mol Med 2010, 14, 2109–2121.
   PubMed Web of Science ®Google Scholar
• Landsteiner, K., van der Scheer, J. On the serological specificity of peptides. III. J Exp Med 1939, 69, 705–719.
   PubMedGoogle Scholar
• Lucchese, G., Stufano, A., Trost, B., Kusalik, A., Kanduc, D. Peptidology: Short amino acid modules in cell biology and immunology. Amino Acids 2007, 33, 703–707.
   PubMed Web of Science ®Google Scholar
• Tassi, G.C., Valcurone, G. [Atopy and RAST. Diagnostic, therapeutic and standardization problems. Experimental contribution (allergy to antibiotics)]. Boll Ist Sieroter Milan 1978, 57, 557–574.
   PubMedGoogle Scholar
• Cohen, G.A., O’Connor, R.D., Hamburger, R.N. Safety and efficacy of human IgE pentapeptide. Ann Allergy 1984, 52, 83–86.
   PubMedGoogle Scholar
• Marone, G., Columbo, M., Soppelsa, L., Condorelli, M. The mechanism of basophil histamine release induced by pepstatin A. J Immunol 1984, 133, 1542–1546.
   PubMed Web of Science ®Google Scholar
• Hobbs, M.V., Morgan, E.L., Houghten, R.A., Thoman, M.L., Weigle, W.O. Identification of a lymphocyte-activating pentapeptide sequence in the Fc region of human IgG1. J Immunol 1987, 138, 2581–2586.
   PubMed Web of Science ®Google Scholar
• Zagury, J.F., Lachgar, A., Achour, A., Chams-Harvey, V., Cho, Y.Y., Le Coq, H., Bizzini, B., Feldman, M., Burny, A., Zagury, D. Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS. Biomed Pharmacother 1994, 48, 11–16.
   PubMed Web of Science ®Google Scholar
• Abe, T., Satoh, N., Nakajima, A., Koizumi, T., Tamada, M., Sakuragi, S. Characterization of a potent uveitopathogenic site derived from rat phosducin. Exp Eye Res 1997, 65, 703–710.
   PubMed Web of Science ®Google Scholar
• Tanabe, S. Epitope peptides and immunotherapy. Curr Protein Pept Sci 2007, 8, 109–118.
   PubMed Web of Science ®Google Scholar
• Lucchese, G., Calabro, M., Kanduc, D. Circumscribing the conformational peptide epitope landscape. Curr Pharm Des 2012, 18, 832–839.
   PubMed Web of Science ®Google Scholar
• Lucchese, G., Sinha, A.A., Kanduc, D. How a single amino acid change may alter the immunological information of a peptide. Front Biosci (Elite Ed) 2012, 4, 1843–1852.
   PubMedGoogle Scholar
• Cubitt, C.L., Cui, X., Agostini, H.T., Nerurkar, V.R., Scheirich, I., Yanagihara, R., Ryschkewitsch, C.F., Stoner, G.L. Predicted amino acid sequences for 100 JCV strains. J Neurovirol 2001, 7, 339–344.
   PubMed Web of Science ®Google Scholar
• Du Pasquier, R.A., Kuroda, M.J., Schmitz, J.E., Zheng, Y., Martin, K., Peyerl, F.W., Lifton, M., Gorgone, D., Autissier, P., Letvin, N.L., Koralnik, I.J. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J Virol 2003, 77, 11918–11926.
   PubMed Web of Science ®Google Scholar
• Li, J., Melenhorst, J., Hensel, N., Rezvani, K., Sconocchia, G., Kilical, Y., Hou, J., Curfman, B., Major, E., Barrett, A.J. T-cell responses to peptide fragments of the BK virus T antigen: Implications for cross-reactivity of immune response to JC virus. J Gen Virol 2006, 87, 2951–2960.
   PubMed Web of Science ®Google Scholar
• Sharma, M.C., Zhou, W., Martinez, J., Krymskaya, L., Srivastava, T., Haq, W., Diamond, D.J., Lacey, S.F. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals. Virology 2006, 350, 128–136.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Trofe, J., Gordon, J., Autissier, P., Woodle, E.S., Koralnik, I.J. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 2008, 42, 198–202.
   PubMed Web of Science ®Google Scholar
• Lima, M.A., Marzocchetti, A., Autissier, P., Tompkins, T., Chen, Y., Gordon, J., Clifford, D.B., Gandhi, R.T., Venna, N., Berger, J.R., Koralnik, I.J. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 2007, 81, 3361–3368.
   PubMed Web of Science ®Google Scholar
• Mao, Y.S., Lu, C.Z., Wang, X., Xiao, B.G. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein. Exp Neurol 2007, 206, 231–239.
   PubMed Web of Science ®Google Scholar
• Ramaswami, B., Popescu, I., Macedo, C., Luo, C., Shapiro, R., Metes, D., Chalasani, G., Randhawa, P.S. The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response. Clin Vaccine Immunol 2011, 18, 815–824.
   PubMedGoogle Scholar
• Lucchese, G., Stufano, A., Kanduc, D. Proteome-guided search for influenza A B-cell epitopes. FEMS Immunol Med Microbiol 2009, 57, 88–92.
   PubMedGoogle Scholar
• Kanduc, D., Tessitore, L., Lucchese, G., Kusalik, A., Farber, E., Marincola, F.M. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol Immunother 2008, 57, 1215–1223.
   PubMed Web of Science ®Google Scholar
• Polimeno, L., Mittelman, A., Gennero, L., Ponzetto, A., Lucchese, G., Stufano, A., Kusalik, A., Kanduc, D. Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis. Amino Acids 2008, 34, 479–484.
   PubMed Web of Science ®Google Scholar
• Yan, H.X., Yang, W., Zhang, R., Chen, L., Tang, L., Zhai, B., Liu, S.Q., Cao, H.F., Man, X.B., Wu, H.P., Wu, M.C., Wang, H.Y. Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. J Biol Chem 2006, 281, 15423–15433.
   PubMed Web of Science ®Google Scholar
• Makoukji, J., Shackleford, G., Meffre, D., Grenier, J., Liere, P., Lobaccaro, J.M., Schumacher, M., Massaad, C. Interplay between LXR and Wnt/ß-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols. J Neurosci 2011, 31, 9620–9629.
   PubMed Web of Science ®Google Scholar
• Seeling, J.M., Miller, J.R., Gil, R., Moon, R.T., White, R., Virshup, D.M. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 1999, 283, 2089–2091.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Trofe, J., Gordon, J., Du Pasquier, R.A., Roy-Chaudhury, P., Kuroda, M.J., Woodle, E.S., Khalili, K., Koralnik, I.J. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 2006, 80, 3495–3505.
   PubMed Web of Science ®Google Scholar
• Krymskaya, L., Sharma, M.C., Martinez, J., Haq, W., Huang, E.C., Limaye, A.P., Diamond, D.J., Lacey, S.F. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005, 79, 11170–11178.
   PubMed Web of Science ®Google Scholar
• Ibi, D., Nitta, A., Ishige, K., Cen, X., Ohtakara, T., Nabeshima, T., Ito, Y. Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 region. Neurochem Int 2010, 56, 77–83.
   PubMed Web of Science ®Google Scholar
• Hashida, H., Goto, J., Zhao, N., Takahashi, N., Hirai, M., Kanazawa, I., Sakaki, Y. Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA). Genomics 1998, 54, 50–58.
   PubMed Web of Science ®Google Scholar
• Parfitt, D.A., Michael, G.J., Vermeulen, E.G., Prodromou, N.V., Webb, T.R., Gallo, J.M., Cheetham, M.E., Nicoll, W.S., Blatch, G.L., Chapple, J.P. The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. Hum Mol Genet 2009, 18, 1556–1565.
   PubMed Web of Science ®Google Scholar
• Koralnik, I.J., Du Pasquier, R.A., Kuroda, M.J., Schmitz, J.E., Dang, X., Zheng, Y., Lifton, M., Letvin, N.L. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 2002, 168, 499–504.
   PubMed Web of Science ®Google Scholar
• Matsuoka, H., Obama, H., Kelly, M.L., Matsui, T., Nakamoto, M. Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration. J Biol Chem 2005, 280, 29355–29363.
   PubMed Web of Science ®Google Scholar
• Matsuoka, H., Iwata, N., Ito, M., Shimoyama, M., Nagata, A., Chihara, K., Takai, S., Matsui, T. Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem Biophys Res Commun 1997, 235, 487–492.
   PubMed Web of Science ®Google Scholar
• Cholay, M., Reverdy, C., Benarous, R., Colland, F., Daviet, L. Functional interaction between the ubiquitin-specific protease 25 and the SYK tyrosine kinase. Exp Cell Res 2010, 316, 667–675.
   PubMed Web of Science ®Google Scholar
• Miller, C.L., Burkhardt, A.L., Lee, J.H., Stealey, B., Longnecker, R., Bolen, J.B., Kieff, E. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 1995, 2, 155–166.
   PubMed Web of Science ®Google Scholar
• Perides, G., Rahemtulla, F., Lane, W.S., Asher, R.A., Bignami, A. Isolation of a large aggregating proteoglycan from human brain. J Biol Chem 1992, 267, 23883–23887.
   PubMed Web of Science ®Google Scholar
• Dours-Zimmermann, M.T., Maurer, K., Rauch, U., Stoffel, W., Fässler, R., Zimmermann, D.R. Versican V2 assembles the extracellular matrix surrounding the nodes of ranvier in the CNS. J Neurosci 2009, 29, 7731–7742.
   PubMed Web of Science ®Google Scholar
• Melendez-Vasquez, C., Carey, D.J., Zanazzi, G., Reizes, O., Maurel, P., Salzer, J.L. Differential expression of proteoglycans at central and peripheral nodes of Ranvier. Glia 2005, 52, 301–308.
   PubMed Web of Science ®Google Scholar
• Du Pasquier, R.A., Stein, M.C., Lima, M.A., Dang, X., Jean-Jacques, J., Zheng, Y., Letvin, N.L., Koralnik, I.J. JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients. J Neuroimmunol 2006, 176, 181–186.
   PubMed Web of Science ®Google Scholar
• Reddehase, M.J., Rothbard, J.B., Koszinowski, U.H. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 1989, 337, 651–653.
   PubMed Web of Science ®Google Scholar
• Hemmer, B., Kondo, T., Gran, B., Pinilla, C., Cortese, I., Pascal, J., Tzou, A., McFarland, H.F., Houghten, R., Martin, R. Minimal peptide length requirements for CD4(+) T cell clones–implications for molecular mimicry and T cell survival. Int Immunol 2000, 12, 375–383.
   PubMed Web of Science ®Google Scholar
• Rothbard, J.B., Gefter, M.L. Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 1991, 9, 527–565.
   PubMed Web of Science ®Google Scholar
• Tiwari, R., Geliebter, J., Lucchese, A., Mittelman, A., Kanduc, D. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity. Peptides 2004, 25, 1865–1871.
   PubMed Web of Science ®Google Scholar
• Lucchese, G., Stufano, A., Kanduc, D. Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis. J Biomed Biotechnol 2010, 2010, 832341.
   PubMedGoogle Scholar
• Kanduc, D. The self/nonself issue: A confrontation between proteomes. Self Nonself 2010, 1, 255–258.
   PubMedGoogle Scholar
• Kanduc, D. Peptide cross-reactivity: The original sin of vaccines. Front Biosci 2012, 4, 1393–1401.
   Google Scholar
• Lucchese, G. Confronting JC virus and Homo sapiens biological signatures. Front Biosci 2012, in press.
   Google Scholar
• Lucchese, G., Stufano, A., Calabro, M., Kanduc, D. Charting the peptide crossreactome between HIV-1 and the human proteome. Front Biosci (Elite Ed) 2011, 3, 1385–1400.
   PubMedGoogle Scholar
• Lucchese, G., Stufano, A., Kanduc, D. Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide. Self Nonself 2011, 2, 49–54.
   PubMedGoogle Scholar
• Lucchese, G., Pesce Delfino, A. Using proteomics to develop an anti-Campylobacter jejuni vaccine. Immunopharmacol Immunotoxicol 2012. doi:10.3109/08923973.2011.608685
   Google Scholar